Chardan Capital Markets, LLC is an investment bank. The firm provides financing, private placements, restructuring, fairness opinion, special situations, mergers and acquisitions services. Additionally, the firm provides debt financing, private equity financing, venture capital funding, equities and options trading, and non deal road shows services. The firm advises public and private companies, investors, shareholders and strategic groups on financings and strategic transactions. The firm caters to technology, healthcare sectors. Chardan Capital Markets, LLC was founded in 2002 and is based in New York, New York.


Chardan focuses on innovative healthcare companies that deliver remarkable investment returns because of the tremendous value they generate for society.


At Chardan, we identified genetic medicines as an exemplar of disruptive innovation about 5 years ago. Since that time, we have built the leading global coverage in the space, with 28 names under coverage.

We are able to uncover the next big thing ahead of the rest of Wall Street because of our strong scientific foundation—evident in our industry-leading frameworks and weekly pieces—and our independent voice. Our influence extends beyond printed research to our hosted conferences, where we bring together the best companies, investors, and other industry innovators around the world.

Chardan’s genetic medicines practice is led by preeminent analyst Dr. Gbola Amusa, who has advised governments, NGOs, and other industry stakeholders on various healthcare policies and financial issues.